Interestingly, patient data from the TCGA support the conclusion that CMTM6 plays different roles in CRC and HCC; CMTM6 expression is upregulated in patient CRC tissues but downregulated in HCC tissues compared to normal control tissues. Here, CMTM6 is linked to hepatocellular carcinoma.